About
Elgan Pharma is a late-stage biotech company focused on developing safe, non-invasive therapies for preterm infants, targeting intestinal malabsorption and prevention of vision impairment caused by retinopathy of prematurity.
Explore Elgan Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.